valuation thoughts, page-375

@ProPunter23Red

judging by current share prices for biotech companies regardless of where domiciled or listed, all biotech Boards and CEO's have stuffed it up royally.

peope seem to be struggling with how changes in interest rates effect the share market and particluar sectors

Chow hasn't put a foot wrong


tough to make people happy

Management chips in and offers to retail a piece of the action - people complain that it won't be supported

if management offers only to soph's - people complain its a discounted raise to the big end and mates

You may be surprised what they are working on in terms of funding... we need to understand that we cannot see all that is happening within the company and maybe slow down before jumping at shadows with a lack of information

we are yet to see what they are presenting as tehy may only need to raise a few months now and then raise to sophs or utilise L1 raise once more is known

know what you know and know what you don't know